pubmed-article:14576131 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0030946 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
pubmed-article:14576131 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
pubmed-article:14576131 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:14576131 | pubmed:dateCreated | 2003-10-24 | lld:pubmed |
pubmed-article:14576131 | pubmed:abstractText | In 243 antiretroviral-naive human immunodeficiency-infected patients starting a first-line-protease inhibitor (mainly nelfinavir)-containing therapy, the presence of the polymorphism R57K in the protease at the inception of therapy was independently associated with a higher rate of virological failure. | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:language | eng | lld:pubmed |
pubmed-article:14576131 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14576131 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14576131 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14576131 | pubmed:month | Nov | lld:pubmed |
pubmed-article:14576131 | pubmed:issn | 0066-4804 | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:ChêneGenevièv... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:MasquelierBer... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:RaffiFrançois... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:Brun-VézinetF... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:DescampsDiane... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:PerronneChris... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:SpireBrunoB | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:FerréVirginie... | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:DrozCecileC | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:DaryMartinM | lld:pubmed |
pubmed-article:14576131 | pubmed:author | pubmed-author:APROCO/COPILO... | lld:pubmed |
pubmed-article:14576131 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14576131 | pubmed:volume | 47 | lld:pubmed |
pubmed-article:14576131 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14576131 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14576131 | pubmed:pagination | 3623-6 | lld:pubmed |
pubmed-article:14576131 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:meshHeading | pubmed-meshheading:14576131... | lld:pubmed |
pubmed-article:14576131 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14576131 | pubmed:articleTitle | R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen. | lld:pubmed |
pubmed-article:14576131 | pubmed:affiliation | Laboratoire de Virologie, Hôpital Pellegrin, Bordeaux, France. bernard.masquelier@chu-bordeaux.fr | lld:pubmed |
pubmed-article:14576131 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14576131 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14576131 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14576131 | lld:pubmed |